News

People who have experienced brain fog, confusion, pain, and extreme fatigue for months or longer after being infected with the COVID-19 virus exhibit different immune and hormonal responses to the virus than those not diagnosed with long COVID.

Macrophages are little cells vital to the immune system and could inform cell-based therapies. However, realizing the full potential of macrophage therapies relies on being able to see what these cellular allies are doing inside our bodies.

Artemisinin-based combination therapies (ACTs) are globally accepted first-line treatments for malaria, but resistance to ACTs has emerged in recent years. Scientists have now found that next-generation interventions can reduce the rate of treatment failure by at least 81%.

Pregnancy changes the human body dramatically. One of the smallest alterations that pregnancy produces may also be the most important, suggests new research exploring cell populations passed between mother and child.

For the first time, a genetic biomarker has been identified that could help predict the severity of food allergic reactions.

Scientists have discovered a new virus isolated from sediment brought up from a depth of 8,900 meters. The virus is a bacteriophage – a virus that infects and replicates inside bacteria – and is thought to be the deepest known isolated phage to date.

A new study has analyzed the genomes of bats to investigate their ability to tolerate viral infections and avoid cancer – findings that could have implications for our knowledge of human cancers as well as virus transmission from animals.

Klebsiella pneumoniae causes a variety of afflictions and can be deadly. Researchers have now shown which strains are more likely to survive in human blood and serum, and which are more susceptible to the human immune system.

Scientists have developed a powerful diagnostic tool capable of detecting monkeypox virus in clinical samples with acute precision and at a faster rate than any other method.

Scientists hoping to make bio-based manufacturing more renewable and carbon-neutral have developed a new workflow that combines CRISPR gene editing and computational models of microbial gene expression and enzyme activity.